Xiangju Kong

Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation.

Robert Damoiseaux, Antoni Ribas, Mark C Kelley, 2017, Cancer discovery.

Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance

Antoni Ribas, Kimberly B. Dahlman, Hubing Shi, 2015, Cell.

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)

Tom Misteli, Mark C. Kelley, Neal Rosen, 2011, Nature.

Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.

Antoni Ribas, Hubing Shi, Mark C Kelley, 2014, Cancer discovery.

A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.

Antoni Ribas, Hubing Shi, Richard A Scolyer, 2014, Cancer discovery.